Viewing Study NCT02323659


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-24 @ 3:03 PM
Study NCT ID: NCT02323659
Status: TERMINATED
Last Update Posted: 2022-01-13
First Post: 2014-12-12
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Sponsor: Polish Lymphoma Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module